AXL and pleural mesothelioma: Overall, our findings are in agreement with evidence obtained in pleural mesothelioma cell lines that displayed co-activation of EGFR, Axl, and MET, supporting the hypothesis of a higher responsiveness to combined targeted therapies [24,25].